Merck KGaA (MRK) News Today → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free MRK Stock Alerts €167.20 -1.50 (-0.89%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesStock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 7:40 PM | benzinga.comCheck Out What Whales Are Doing With MRKMay 13, 2024 | msn.comMerck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma TreatmentMay 13, 2024 | markets.businessinsider.comMerck Discontinues Vibostolimab And Pembrolizumab Coformulation Arm Of Phase 3 Trial In MelanomaMay 10, 2024 | seekingalpha.comMerck: The Worst Has Been Avoided (Rating Upgrade)May 9, 2024 | markets.businessinsider.comMerck' Keytruda Receives Approval From Health Canada For Biliary Tract Carcinoma In AdultsMay 8, 2024 | msn.com[INTERVIEW] Merck will expand partnerships with Korean chip makers: executive VPApril 30, 2024 | markets.businessinsider.comBuy Rating Affirmed on Merck & Company Following Strong Q1 Performance and Upbeat Full-Year GuidanceApril 29, 2024 | finanznachrichten.deHUMA Therapeutics: Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer PatientsApril 26, 2024 | fool.comMerck Shines in Q1 2024 Earnings SurgeApril 19, 2024 | benzinga.comMerck & Co Stock (NYSE:MRK), Analyst Ratings, Price Targets, PredictionsApril 19, 2024 | markets.businessinsider.comHealth Canada Approves Merck's Keytruda Plus Chemotherapy To Treat Gastric CancersApril 18, 2024 | benzinga.comUnveiling 17 Analyst Insights On Merck & CoApril 14, 2024 | msn.comMerck Paid $208 Million to Stop Its Drugs From Working. Here's Why That's Bullish.April 12, 2024 | markets.businessinsider.comMerck & Company: Balancing Growth Prospects Against Rising Operational ChallengesApril 6, 2024 | markets.businessinsider.comMerck & Company (MRK) Receives a Buy from Cantor FitzgeraldApril 4, 2024 | markets.businessinsider.comMerck Begins Phase 3 Trial Of MK-1084 As First-Line Treatment Of Certain Metastatic NSCLC PatientsMarch 28, 2024 | msn.comMerck Stock Hits Record High as FDA Approves Its Cardiovascular Disease DrugMarch 27, 2024 | markets.businessinsider.comFDA Approves Merck's Winrevair For Treatment Of Pulmonary Arterial Hypertension In AdultsMarch 26, 2024 | finanznachrichten.deMerck & Co., Inc.: Merck Foundation Strengthens Its Commitment to Expanding Access to Care in Asia-Pacific RegionMarch 19, 2024 | finance.yahoo.comMerck KGaA (ETR:MRK) Is Paying Out A Dividend Of €2.20March 15, 2024 | msn.comMerck hits main goal for Keytruda in late-stage trial for cervical cancerMarch 11, 2024 | msn.comSociete General cuts Merck to sell, cites Keytruda patent expiryMarch 7, 2024 | finance.yahoo.comMerck KGaA Expects Organic Sales, Earnings Growth This YearMarch 4, 2024 | finanznachrichten.deC4 Therapeutics, Inc.: C4 Therapeutics Announces Strategic Discovery Research Collaboration withFebruary 29, 2024 | markets.businessinsider.comCritical Insights From Merck & Co Analyst Ratings: What You Need To KnowFebruary 29, 2024 | seekingalpha.comMerck: A Great Dividend Growth Stock, But Not At This PriceFebruary 26, 2024 | benzinga.comBehind the Scenes of Merck & Co's Latest Options TrendsFebruary 24, 2024 | finance.yahoo.comMerck KGaA (MRK.BE)February 20, 2024 | markets.businessinsider.comMerck: FDA Grants Priority Review To SBLA For KEYTRUDA Plus Chemotherapy In Endometrial CarcinomaFebruary 12, 2024 | markets.businessinsider.comMerck Says Health Canada Oks KEYTRUDA In Combination With Trastuzumab And ChemotherapyFebruary 5, 2024 | msn.comM & A News: Merck (NYSE:MRK) Snaps Up Elanco’s Aqua Unit for $1.3BFebruary 1, 2024 | benzinga.comMerck Posts Surprise Quarterly Profit Against An Expected Loss, Oncology And Vaccines Drive GrowthFebruary 1, 2024 | msn.comMerck Non-GAAP EPS of $0.03 beats by $0.14, revenue of $14.6B beats by $120MFebruary 1, 2024 | msn.comMerck’s fourth-quarter results top estimates, fueled by key cancer drugs and vaccinesFebruary 1, 2024 | reuters.comMerck posts better-than-expected quarterly results on soaring Keytruda salesFebruary 1, 2024 | msn.comMerck results beat expectations as top drugs Keytruda, Gardasil post strong salesJanuary 29, 2024 | msn.comInvestor Optimism Around Keytruda Drives Merck Stock To Golden Cross Ahead of EarningsJanuary 28, 2024 | msn.comMerck's Multi-Billion Cancer Drug Keytruda Improves Disease-Free Survival In Advanced Bladder Cancer After Surgery, Data ShowsJanuary 15, 2024 | msn.comMerck (NYSE:MRK): FDA Approves Expanded Use of KeytrudaJanuary 12, 2024 | msn.comFDA approves Merck's Keytruda for FIGO 2014 cervical cancerJanuary 12, 2024 | reuters.comMerck's Keytruda combo gets FDA nod for expanded use in cervical cancerJanuary 10, 2024 | finanznachrichten.deMilliporeSigma's Global Food Drive Provides 535,685 MealsJanuary 10, 2024 | markets.businessinsider.comBuy Rating for Merck on Strategic Acquisition of Harpoon Therapeutics and Promising Drug EfficacyJanuary 8, 2024 | msn.comMerck (MRK) Advances But Underperforms Market: Key FactsJanuary 8, 2024 | msn.comMerck in talks to acquire Harpoon Therapeutics for around $700M - BloombergJanuary 5, 2024 | benzinga.comP/E Ratio Insights for Merck & CoJanuary 4, 2024 | msn.comMerck stock poised for sixth straight gain, Cowen upgrades on valuationJanuary 4, 2024 | msn.comMerck stock poised for sixth straight gainJanuary 3, 2024 | msn.comWhy the Market Dipped But Merck (MRK) Gained TodayJanuary 3, 2024 | businesswire.comMerck to Participate in the 42nd Annual J.P. Morgan Healthcare Conference Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk’s PRIME is Set to Shock the World (Ad)Must-See: Elon's New Invention is Absolutely Insane When you click here and see what Elon Musk’s new invention does…You will NOT believe it. But Elon just tested this in a real human… And the result was mind-blowing. Click here for the full story… MRK Media Mentions By Week MRK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼0.030.49▲Average Medical News Sentiment MRK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼33▲MRK Articles Average Week Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bayer Aktiengesellschaft News Today Fresenius Medical Care News Today Carl Zeiss Meditec News Today Siemens Healthineers News Today Evotec News Today Gerresheimer News Today MorphoSys News Today CompuGroup Medical SE & Co. KGaA News Today Stratec News Today Drägerwerk AG & Co. KGaA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ETR:MRK) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceNext President (Not Trump. Not Biden.)The Freeport SocietyWhat’s Really Next for America…Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
